Taking the red out of eosinophilic inflammation in COPD

J Allergy Clin Immunol. 2020 Aug;146(2):278-279. doi: 10.1016/j.jaci.2020.05.028. Epub 2020 Jun 2.

Author

Robert K Bush¹

Affiliation

¹ Department of Medicine, Division of Allergy, Immunology, Pulmonary, Critical Care, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: rkb@medicine.wisc.edu.

PMID: 32502512
DOI: 10.1016/j.jaci.2020.05.028

No abstract available

Keywords: Asthma-COPD overlap; COPD; benralizumab; biologics; eosinophils.

Publication types

Editorial

MeSH terms

Animals
Antibodies, Monoclonal, Humanized / therapeutic use*
Asthma / drug therapy
Asthma / immunology*
Biological Products / therapeutic use*
Eosinophils / immunology*
Humans
Inflammation / drug therapy*
Inflammation / immunology
Pulmonary Disease, Chronic Obstructive / drug therapy*
Pulmonary Disease, Chronic Obstructive / immunology

Substances

Antibodies, Monoclonal, Humanized
Biological Products
benralizumab